Covalon Technologies Ltd. (OTCMKTS:CVALF) Sees Significant Decline in Short Interest

Covalon Technologies Ltd. (OTCMKTS:CVALF) saw a significant decrease in short interest in December. As of December 15th, there was short interest totalling 1,300 shares, a decrease of 50.0% from the November 30th total of 2,600 shares. Based on an average trading volume of 29,100 shares, the short-interest ratio is presently 0.0 days.

Covalon Technologies Trading Down 3.6 %

OTCMKTS:CVALF opened at $2.20 on Friday. The firm’s fifty day simple moving average is $2.50 and its 200 day simple moving average is $2.14. Covalon Technologies has a twelve month low of $0.74 and a twelve month high of $3.08. The firm has a market capitalization of $60.21 million, a price-to-earnings ratio of -73.23 and a beta of -0.31.

Covalon Technologies Company Profile

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.